Research into the metabolic role of glutamine in trauma and sepsis brings evidence to suggest a conditional deficiency occurs because increased and altered tissue demands exceed endogenous production. Such a deficiency has functional implications, and the restorative provision of parenteral glutamine has been shown to offer improved clinical outcomes in a variety of conditions. In the critically-ill it is associated with improvements in immune function, and improved survival from infection leading to an overall improved outcome.
CITATION STYLE
Griffiths, R. D. (2001). The evidence for glutamine use in the critically-ill. Proceedings of the Nutrition Society, 60(3), 403–410. https://doi.org/10.1079/pns200197
Mendeley helps you to discover research relevant for your work.